# FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

> **NCT02055586** · — · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **OTHER:** fluorine F 18 fluorothymidine
- **DEVICE:** positron emission tomography
- **DEVICE:** magnetic resonance imaging

## Key facts

- **NCT ID:** NCT02055586
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-22
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-12-27
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055586, "FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02055586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*